The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) (BMV:DNA) has been revised to $8.16 / share, as of October 20, 2026. This is an increase of 14.29% from the prior estimate of $7.14 dated September 29, 2026. These figures represent aggregate analyst target